hrp0097p1-451 | Fat, Metabolism and Obesity | ESPE2023

Diagnostic Journey with an 80-gene Panel in Non-syndromic Early-Onset Severe Obesity: Association of Outcomes with Metabolic Status and Hyperphagia

Tercan Ummahan , Yildiz Melek , Dilruba Aslanger Ayca , Derya Kardelen Al Asli , Poyrazoglu Sükran , Bas Fİrdevs , Darendeliler Feyza

Background: Monogenic defects are among the significant causes of early-onset non-syndromic severe obesity in childhood. Identifying the genetic cause of obesity can guide for treatment. The aim of our study is to investigate the clinical and biochemical features of patients with early-onset severe obesity and evaluate the underlying molecular diagnosis.Materials and Methods: A total of 39 patients (M/F: 22/17) with non-...

hrp0098p1-157 | GH and IGFs 2 | ESPE2024

The Long-Term Follow-up of Growth Hormone Treatment in a Case with 2q37 Deletion, 14q32 Duplication and Alopecia Totalis

Ceren Eryilmaz Cansu , Derya Kardelen Aslı , Kale Hamdi , Dilruba Aslanger Ayca , Yıldız Melek , Bas Firdevs

Introduction: Brachydactyly mental retardation syndrome (BDMR, #MIM600430) is a rare genetic disorder caused by deletions in 2q37 region, characterised by intellectual disability, facial features, and skeletal abnormalities. This case delineates the clinical progression and growth hormone (GH) therapy response of a patient with a unique phenotype resulting from an unbalanced derivative of a paternal balanced translocation, leading to a 2q37 deletion and 14q32 ...

hrp0098p2-123 | Fat, Metabolism and Obesity | ESPE2024

Evaluation of metabolic syndrome risk using metabolic syndrome z-score in Bardet-Biedl Syndrome patients with various genotypes

Kandemir Tugce , Tercan Ummahan , Bayrak Demirel Ozge , Tugce Yavuz Behiye , Karaman Volkan , Derya Kardelen Al Asli , Dilruba Aslanger Ayca , Yildiz Melek , Poyrazoglu Sukran , Bas Firdevs , Oya Uyguner Zehra , Darendeliler Feyza

Background: Bardet-Biedl syndrome (BBS) is a rare, autosomal recessive, clinically and genetically heterogeneous, pleiotropic disease characterized by the immotile primary cilia, leading to an MC4R pathway impairment. In addition to syndromic features, patients present with hyperphagia, early-onset obesity, metabolic syndrome (MetS) and increased risk of type 2 diabetes. Here, we aimto describe metabolic features and MetS z-score in a group of rare BBS cases.<...

hrp0098p2-302 | Late Breaking | ESPE2024

Clinical and molecular characteristics of 26 patients with P450 oxidoreductase deficiency: A multicenter study

Yildiz Melek , Bayrak Demirel Ozge , Cayir Atilla , Unal Edip , Dilruba Aslanger Ayca , Betul Kaygusuz Sare , Kahveci Ahmet , Akcay Teoman , Turan Ihsan , Demir Korcan , Yildirim Ruken , Kocabey Sutcu Zumrut , Arslan Emrullah , Deniz Papatya Cakir Esra , Akin Leyla , Kiremitci Yilmaz Seniha , Guran Tulay , Bas Firdevs

Background: P450 oxidoreductase (POR) deficiency is a rare cause of congenital adrenal hyperplasia (CAH) with a wide spectrum of clinical phenotypes including glucocorticoid deficiency, difference/disorder of sex development (DSD), skeletal malformations, and Antley-Bixler syndrome. We describe the clinical and molecular characteristics of a large cohort with POR deficiency with long-term data.Methods: The medical record...